Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand

Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand

US Patent 9696312 · Granted Jul 4, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating CD166-expressing cancer2020
Methods of treating CD166-expressing cancer2020
Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand2020
Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand2020
Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand2020
Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand2020
Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand2020
ILT3 polypeptides and uses thereof2017
ILT3 polypeptides and uses thereof2017
ILT3 polypeptides and uses thereof2015
ILT3 polypeptides and uses thereof2015
ILT3 polypeptides and uses thereof2015